Takeda Aims to Boost Growth With $900 Million Tech Overhaul
This article is for subscribers only.
Takeda Pharmaceutical Co. said it will streamline its workforce and lean more heavily on data and technology in a restructuring plan intended to improve growth and profit margins.
The company will take a 140 billion yen ($900 million) charge for the initiative in fiscal year 2024, with additional, lower expenses expected from the restructuring in the following two years, it said in a statement.